×

Hedge fund winners in Allergan deal

12:33 PM ET Mon, 17 Nov 2014

Actavis is buying Allergan for $66 billion. CNBC's Kate Kelly provides insight to speculation surrounding the benefit of the deal to Pershing Square's Bill Ackman.